FibroGen Inc
NASDAQ:FGEN
NASDAQ FSI:D. Deficient (Issuer failed to meet continued listing requirements)

  • LAST PRICE
    0.3347
  • TODAY'S CHANGE (%)
    -0.0352 (-9.5161%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.3712 / 0.3699
  • Day Range
    0.3288
    0.3850
  • 52 Week Range
    0.1800
    2.9300
  • Volume
    1,798,968

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Nov 12, 2024

      Show headlines and story abstract

    • 4:22PM ET on Tuesday Nov 12, 2024 by MT Newswires
      Companies Mentioned: FGEN
      04:22 PM EST, 11/12/2024 (MT Newswires) -- ...

    • 4:22PM ET on Tuesday Nov 12, 2024 by MT Newswires
      Companies Mentioned: FGEN
      04:22 PM EST, 11/12/2024 (MT Newswires) -- ...

    • 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
      Companies Mentioned: FGEN

      (In thousands)
      September 30, 2024 December 31, 2023 -------------------- ------------------- (Unaudited) (1) Assets Current assets: Cash and cash equivalents $ 131,003 $ 113,688 Short-term investments -- 121,898 Accounts receivable, net 29,030 12,553 Inventory 23,937 41,565 Prepaid expenses and other current assets 60,559 41,855 ---------------- -------------- Total current assets 244,529 331,559 Restricted time deposits 1,658 1,658 Property and equipment, net 7,603 13,126 Equity method investment in unconsolidated variable interest entity 5,806 5,290 Operating lease right-of-use assets 2,093 68,093 Other assets 2,732 3,803 ---------------- -------------- Total assets $ 264,421 $ 423,529 ================ ============== Liabilities, stockholders' equity and non-controlling interests Current liabilities: Accounts payable $ 9,238 $ 17,960 Accrued and other liabilities 151,141 172,891 Deferred revenue 28,858 12,740 Operating lease liabilities, current 1,293 14,077 ---------------- -------------- Total current liabilities 190,530 217,668 Product development obligations 18,199 17,763 Deferred revenue, net of current 126,219 157,555 Operating lease liabilities, non-current 707 66,537 Senior secured term loan facilities, non-current 72,779 71,934 Liability related to sale of future revenues, non-current 56,850 51,413 Other long-term liabilities 837 2,858 ---------------- -------------- Total liabilities 466,121 585,728 Redeemable non-controlling interests 21,480 21,480 Total stockholders' deficit attributable to FibroGen (243,667) (204,166) Nonredeemable non-controlling interests 20,487 20,487 ---------------- -------------- Total deficit (223,180) (183,679) ---------------- -------------- Total liabilities, redeemable non-controlling interests and deficit $ 264,421 $ 423,529 ================ ==============

    • 4:05PM ET on Tuesday Nov 12, 2024 by Dow Jones
      Companies Mentioned: FGEN

  • Nov 4, 2024

Peers Headlines